{
    "organizations": [],
    "uuid": "59c7175c8cbb299e2bf7f3173660e6748bc75b64",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cumberland-pharma-q4-adjusted-earn/brief-cumberland-pharma-q4-adjusted-earnings-per-share-0-03-idUSASB0C924",
    "ord_in_thread": 0,
    "title": "BRIEF-Cumberland Pharma Q4 Adjusted Earnings Per Share $0.03",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Cumberland Pharmaceuticals Inc:\n* CUMBERLAND PHARMACEUTICALS REPORTS 25% REVENUE GROWTH FOR THE FULL YEAR 2017\n* Q4 ADJUSTED EARNINGS PER SHARE $0.03 * Q4 REVENUE ROSE 28 PERCENT TO $11.6 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T05:13:00.000+02:00",
    "crawled": "2018-03-07T19:40:58.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cumberland",
        "pharmaceutical",
        "inc",
        "cumberland",
        "pharmaceutical",
        "report",
        "revenue",
        "growth",
        "full",
        "year",
        "q4",
        "adjusted",
        "earnings",
        "per",
        "share",
        "q4",
        "revenue",
        "rose",
        "percent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}